Levodropropizine

Levodropropizine

Gene therapy
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	R05DB27 (WHO)
Physiological data
Legal status
Pharmacokinetic data
Protein binding	11-14%
Excretion	83% via urine within 96 h
Identifiers
IUPAC name (2S)-3-(4-phenylpiperazin-1-yl)propane-1,2-diol
CAS Number	99291-25-5 Y
PubChem Template:Abbreviation	65859
ChemSpider	59270 Y
UNII	3O31P6T4G3
KEGG	D08119 Y
ChEBI	CHEBI:82722 N
Chemical and physical data
Formula	C13H20N2O2
Molar mass	236.31 g/mol
3D model (JSmol)	Interactive image
SMILES O[C@@H](CN2CCN(c1ccccc1)CC2)CO
InChI InChI=1S/C13H20N2O2/c16-11-13(17)10-14-6-8-15(9-7-14)12-4-2-1-3-5-12/h1-5,13,16-17H,6-11H2/t13-/m0/s1 Y Key:PTVWPYVOOKLBCG-ZDUSSCGKSA-N Y
Template:XmarkY (what is this?)  (verify)

WikiDoc Resources for Levodropropizine
Articles
Most recent articles on Levodropropizine Most cited articles on Levodropropizine Review articles on Levodropropizine Articles on Levodropropizine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Levodropropizine Images of Levodropropizine Photos of Levodropropizine Podcasts & MP3s on Levodropropizine Videos on Levodropropizine
Evidence Based Medicine
Cochrane Collaboration on Levodropropizine Bandolier on Levodropropizine TRIP on Levodropropizine
Clinical Trials
Ongoing Trials on Levodropropizine at Clinical Trials.gov Trial results on Levodropropizine Clinical Trials on Levodropropizine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Levodropropizine NICE Guidance on Levodropropizine NHS PRODIGY Guidance FDA on Levodropropizine CDC on Levodropropizine
Books
Books on Levodropropizine
News
Levodropropizine in the news Be alerted to news on Levodropropizine News trends on Levodropropizine
Commentary
Blogs on Levodropropizine
Definitions
Definitions of Levodropropizine
Patient Resources / Community
Patient resources on Levodropropizine Discussion groups on Levodropropizine Patient Handouts on Levodropropizine Directions to Hospitals Treating Levodropropizine Risk calculators and risk factors for Levodropropizine
Healthcare Provider Resources
Symptoms of Levodropropizine Causes & Risk Factors for Levodropropizine Diagnostic studies for Levodropropizine Treatment of Levodropropizine
Continuing Medical Education (CME)
CME Programs on Levodropropizine
International
Levodropropizine en Espanol Levodropropizine en Francais
Business
Levodropropizine in the Marketplace Patents on Levodropropizine
Experimental / Informatics
List of terms related to Levodropropizine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Levodropropizine is a cough suppressant. It is the levo isomer of dropropizine. It acts as a peripheral antitussive, with no action in the central nervous system. It does not cause side effects such as constipation or respiratory depression which can be produced by opioid antitussives such as codeine and its derivatives.

References

Template:Respiratory-system-drug-stub